The most recent safety pilot involved two healthy adults who received intravenous BPC-157 infusions the treatment was well tolerated with no adverse events and plasma concentrations returned to baseline within 24 hours
Therefore, while preclinical data provides a strong rationale for investigation, it must be viewed as hypothesis-generating, not as a direct prediction of human outcomes
For many women, one of the most unexpected side effects of beginning a GLP-1 or GIP medication is a shift in their menstrual cycle
A 2025 prospective, single-blind, randomised study evaluated a biomimetic peptide solution in the context of FUE hair transplantation
Remarkably, users who started GLP-1 treatments within this timeframe account for nearly one-quarter of the Total Store unit decline, underscoring the broader market impact of these medications, Nielsen said